Clinical Research Scientist Calls for Blinded Drug Application Submissions to the FDA

🚨Here’s a simple action that could DRAMATICALLY improve scientific integrity, says @DrFynderella:

"The data uploaded in the system and the IND, which is the investigational new drug application - if all of that was blinded as to what company or who did it, and just the data is uploaded, and it has to be looked at objectively by the team, it could change a lot of things.

It could change the speed of an approval. It could change the approval itself. It could take something that really has promise from a nobody and bring it to the forefront.

To me, that's pure innovation. That's unbiased innovation. There's no name behind it. You don't know whether there are billions of dollars behind it or if it's a rag-tag group of five scientists that left pharma and formed their own group.

You know nothing about it. You have an electronic file with all of the data there, and you have no idea where it came from, but it's following the regulatory process and the review period.”